Your search returned 6 results.

Results
	1.	Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects. [electronic resource] by Kosoglou, Teddy Reyderman, Larisa Tiessen, Renger G van Vliet, André A Fales, Robert R Keller, Robert Yang, Bo Cutler, David L Producer: 20120702 In: European journal of clinical pharmacology vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. [electronic resource] by Tiessen, Renger G Kennedy, Ciara A Keller, Bradley T Levin, Nancy Acevedo, Lisette Gedulin, Bronislava van Vliet, Andre A Dorenbaum, Alejandro Palmer, Melissa Producer: 20180730 In: BMC gastroenterology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. [electronic resource] by van Werven, Jochem R Hoogduin, Johannes M Nederveen, Aart J van Vliet, Andre A Wajs, Ewa Vandenberk, Petra Stroes, Erik S G Stoker, Jaap Producer: 20090922 In: Journal of magnetic resonance imaging : JMRI vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Total energy expenditure assessed by salivary doubly labelled water analysis and its relevance for short-term energy balance in humans. [electronic resource] by Guidotti, Stefano Verstappen-Dumoulin, Berthe M A A A Jansen, Henk G Aerts-Bijma, Anita T van Vliet, André A Scheurink, Anton J W Meijer, Harro A J van Dijk, Gertjan Producer: 20160927 In: Rapid communications in mass spectrometry : RCM vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients. [electronic resource] by de Bruijne, Joep Bergmann, Jilling F Reesink, Henk W Weegink, Christine J Molenkamp, Richard Schinkel, Janke Tong, Xiao Li, Jing Treitel, Michelle A Hughes, Eric A van Lier, Jan Jaap van Vliet, Andre A Janssen, Harry L A de Knegt, Robert J Producer: 20101124 In: Hepatology (Baltimore, Md.) vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7. [electronic resource] by Boonstra, Andre Liu, Bi-Sheng Groothuismink, Zwier M A Bergmann, Jilling F de Bruijne, Joep Hotho, Daphne M Hansen, Bettina E van Vliet, Andre A van de Wetering de Rooij, Jeroen Fletcher, Simon P Bauman, Lisa A Rahimy, Mohamad Appleman, James R Freddo, James L Reesink, Hendrik W de Knegt, Robert J Janssen, Harry L A Producer: 20120905 In: Antiviral therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)